E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/29/2014 in the Prospect News PIPE Daily.

BioSig takes in $339,500 through private placement of its equity units

Offering sells 135,800 common shares and warrants for 203,700 shares

By Devika Patel

Knoxville, Tenn., Dec. 29 – BioSig Technologies, Inc. settled a $339,500 private placement of units on Dec. 19, according to an 8-K filed Monday with the Securities and Exchange Commission. MDB Capital Group, LLC was the agent.

The company sold 3.395 units at $100,000 per unit, issuing a total of 135,800 common shares and two warrants for a total of 203,700 shares.

The first warrant is exercisable for 135,800 shares at $2.50. The second warrant is exercisable for 67,900 shares. The strike price of the first warrant is an 11.66% discount to the Dec. 18 closing share price of $2.83.

Proceeds will be used for general working capital purposes.

The medical device company is based in Los Angeles.

Issuer:BioSig Technologies, Inc.
Issue:Units for a total of 135,800 common shares and two warrants for a total of 203,700 shares
Amount:$339,500
Units:3.395
Price:$100,000
Warrants:Two warrants for a total of 203,700 shares per unit
Warrant strike price:$2.50 (for 135,800 shares)
Settlement date:Dec. 19
Stock symbol:OTCBB: BSGM
Stock price:$2.83 at close Dec. 18
Market capitalization:$30.82 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.